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Abstract
Background: Spatio-temporal control of extracellular signal-regulated kinase (ERK) activity, a
critical determinant of the cell's response to growth factors, requires timely dephosphorylation of
its regulatory tyrosine and/or threonine residue by MAPK phosphatases. We studied the
physiological role of kinase interaction motif (KIM)-containing protein tyrosine phosphatases
(PTPs) in the control of EGF- and NGF-induced ERK activity in neuroendocrine PC12 cells.
Results: We found a single KIM-containing PTP to be endogenously expressed in rat PC12 cells:
the transmembrane PTPRR isoform termed PCPTP1. Protein knock-down of PCPTP1, or fourfold
overexpression of its mouse orthologue, PTPBR7, left EGF- and NGF-induced ERK1/2 activity in
PC12 cells unaltered. Ectopic expression of cytosolic PTPRR isoforms, however, resulted in
reduced EGF-induced ERK1/2 activity, an effect that was dependent on the phosphatase activity and
the KIM-domain of these PTPs.
Conclusion: The finding that robust changes in tyrosine-specific MAPK phosphatase expression
levels have minor effects on temporal ERK1/2 activity control in PC12 cells suggests that dual-
specificity MAPK phosphatases may act as major regulators of growth factor-induced ERK1/2
signaling in these cells.
Background
One of the best-studied cellular signaling relays is the
mitogen-activated protein kinase (MAPK) signaling cas-
cade, the central mechanism by which growth factors steer
cellular key decisions such as proliferation and differenti-
ation [1]. It has become clear that it is not just the ampli-
tude but also the spatio-temporal distribution of the
MAPK activity within the cell that determines the final
outcome of this signaling relay. For example, in the rat
PC12 phaeochromocytoma cell line seminal studies have
shown that epidermal growth factor (EGF)-induced pro-
liferation relies on a transient activation of the extracellu-
lar signal-regulated kinases 1 and 2 (ERK1/2) in the
cytosol, whereas nerve growth factor (NGF)-induced dif-
ferentiation requires a sustained ERK1/2 activation and
translocation to the nucleus [2,3]. Thus, not only signal-
ing molecules that activate these ubiquitous MAPKs but
also the ones that inactivate and/or localize them are
important for determining signaling specificity. ERK acti-
vation requires the phosphorylation of two closely spaced
regulatory tyrosine and threonine residues by the dual
specificity MAP kinase kinases MEK1/2 [4]. Concomi-
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tantly, ERK inactivation involves dephosphorylation of
these residues by MAPK phosphatases. Although the EGF
and NGF specific pathways that lead to ERK activation
have been mapped in detail in PC12 cells [3], the contri-
bution of MAPK phosphatases in this model system has
received little attention.
The dephosphorylation of ERK1/2 regulatory tyrosine and
threonine residues can be achieved by three different
phosphatase types: protein serine/threonine phos-
phatases, dual specificity (serine/threonine/tyrosine)
phosphatases (MKPs/DUSPs) and classical phosphotyro-
sine-specific protein tyrosine phosphatases (PTPs) [5].
The latter two types have gained considerable interest
because they contain a so-called kinase interaction motif
(KIM) that is also present in the upstream MAPK kinases
MEK1/2. The KIM-domain mediates the interaction and
in part determines binding specificity towards the differ-
ent MAPKs [6-8]. Importantly, this interaction can be reg-
ulated via cAMP because PKA-mediated phosphorylation
of a serine residue within the KIM-domain abolishes
binding and dephosphorylation of MAPKs [9,10].
Mammals contain three classical PTP families that may
regulate ERK activity by KIM-dependent binding and
dephosphorylation: HePTP/LC-PTP, STEP and PTPRR
(Fig. 1A). The haematopoietic HePTP/LC-PTP was indeed
shown, through gene targeting studies, to be a physiolog-
ical regulator of ERK in lymphocytes [11] and the striatal-
enriched phosphatase (STEP) enzyme family was found
to regulate ERK activity in primary neuronal cultures [12].
For PTPRR isoforms current data mainly reflect overex-
Tyrosine-specific MAPK phosphatases expressed in PC12 cells Figure 1
Tyrosine-specific MAPK phosphatases expressed in PC12 cells. A) Schematic diagrams of STEP (STEP61, STEP46), 
HePTP and PTPRR (PTPBR7, PTP-SL, PTPPBSγ-42, PTPPBSγ-37) protein isoforms. Mouse isoform nomenclature is given on 
the right. Signal peptides (SP), proline-rich and PEST domains (PP), transmembrane segments (TM), kinase-interacting motifs 
(KIM), hydrophobic regions (HR) and catalytic phosphotyrosine phosphatase domains (PTP) are indicated. B) Assessment of 
KIM-containing, tyrosine-specific PTP expression by RT-PCR. Rat protein nomenclature is indicated on the left, aligned with 
the diagrams of the mouse orthologs depicted in panel A). STEP and HePTP transcripts, as detected by RT-PCR (+) in mouse 
cerebrum (CRB) and spleen (SPL) RNA, respectively, are not found in PC12 cells. For rat PTPRR proteins (PCPTP1, PCPTP1-
Ce, PTPPBSγ) isoform-specific primer sets were used on rat cerebellum (CBL) and PC12 total RNA. Samples lacking RT 
enzyme (-) and appropriate plasmids (p) served as negative and positive controls, respectively. A β-actin specific RT-PCR 
served as a positive control for the reverse transcriptase reactions.Journal of Molecular Signaling 2006, 1:4 http://www.jmolecularsignaling.com/content/1/1/4
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pression studies in non-neuronal cells [6,9,13]. Given that
rat PTPRR receptor-type isoform (PCPTP1) mRNA levels
in PC12 cells are increased nine-fold within 8 h following
NGF treatment [14], a role in neuronal differentiation
induced by sustained ERK activity may be expected.
In the current study we assessed the contribution of the
KIM-domain-containing classical PTPs to the regulation
of ERK activity in rat PC12 cells. HePTP and STEP mRNAs
were not detectable in PC12 cells. For the PTPRR gene a
single transcript type, encoding the transmembrane iso-
form PCPTP1, was encountered. We exploited retroviral
transduction to increase or decrease PTPRR protein levels
and monitored growth factor-induced ERK activation
using phosphospecific antibodies. Our results demon-
strate that KIM-domain-containing tyrosine-specific PTPs
are dispensable for proper ERK-dependent signaling in
PC12 cells and put forward the dual-specificity MAPK
phosphatases as the physiological regulators of ERK activ-
ity in these cells.
Results
A single classical KIM-containing PTP is expressed in PC12 
cells
To determine which of the three KIM-containing phos-
photyrosine-specific PTPs are endogenously expressed in
rat PC12 cells, an RT-PCR analysis on total RNA was per-
formed. Expected amplicons for STEP and HePTP were
obtained from mouse cerebrum and mouse spleen RNA,
respectively, but STEP and HePTP messengers remained
undetectable in PC12 material (Fig. 1B), in concordance
with earlier reports [15,16]. For the rat PTPRR gene two
different transcripts, encoding PCPTP1 and PCPTP1-Ce,
respectively, have been reported [17,18]. PCPTP1 mRNA
is present in PC12 cells [14,17,19] but PCPTP1-Ce tran-
scripts remain undetectable in PC12 RNA, although the
amplification product is readily obtained using rat cere-
bellum RNA (Fig. 1B). In mouse the PTPRR-encoding
gene generates a third transcript isoform which encodes
two additional protein isoforms (PTPPBSγ-42 and
PTPPBSγ-37) through the use of alternative translation
start sites [20]. To be able to probe for the presence of
putative rat PTPPBSγ variants, we searched in public data-
bases for the rat PTPRR genomic region displaying very
high homology to mouse PTPPBSγ transcript-specific
sequences and designed primers for use in RT-PCR assays.
Indeed, the predicted PTPPBSγ-type fragment was ampli-
fied from rat cerebellum RNA, while mouse PTPPBSγ
cDNA served as positive control, but no signal was
obtained using PC12 material (Fig. 1B). Thus, in rat PC12
cells only the largest PTPRR transcript, that encodes the
receptor-type isoform PCPTP1, is expressed.
We next investigated PTPRR isoform expression in PC12
cells at the protein level. Both Western blot analysis of
PC12 cell lysates and immunoprecipitation experiments
revealed multiple immunoreactive bands (e.g. Fig. 2A and
data not shown) that compare well to patterns obtained
with expression constructs for rat PCPTP1 [17]. Proteins
of around 72 and 65 kDa in size are detected that repre-
sent endogenous rat PCPTP1 and a post-translationally
modified variant, respectively, as is the case for the mouse
ortholog PTPBR7 [20]. These data are in line with PTPRR
isoform PCPTP1 to be the only detectable KIM-containing
phosphotyrosine-specific phosphatase in PC12 cells.
RNAi-mediated knock-down of PCPTP1
To assess whether dephosphorylation by PCPTP1 is of rel-
evance for the regulation of EGF- and NGF-induced ERK
signaling in PC12 cells, we aimed at silencing PCPTP1
expression via RNA interference. Different siRNA
sequences were tested through viral transduction with
pSUPER-Retro [21] and the one targeted to nucleotides
2380–2398 of PCPTP1 resulted in an almost complete
ablation of PCPTP1 protein levels (Fig. 2A). To enable
exclusion of off-target effects in these cells, knockdown
was also rescued by introduction of a retroviral expression
vector encoding PTPBR7, the mouse ortholog of PCPTP1.
Effects on ERK activity following EGF or NGF administra-
tion to serum-starved PC12 cells were monitored over
time by immunoblot analysis of cell lysates using phos-
phospecific ERK1/2 antibodies. Reprobing the same
immunoblot with antiserum directed against total ERK1
enabled us to correct for loading differences between sam-
ples and to express ERK1/2 activity as relative phosphor-
ylation units. EGF administration to mock-transduced
PC12 cells resulted in a very rapid but transient ERK1/2
activation that peaks within the first 5 min (Fig. 2B, upper
panels). Upon NGF treatment, ERK1/2 biphosphoryla-
tion is maximal after some 10 min and then gradually
decreases, with sustained ERK1/2 activity still being
detectable after 48 h (Fig. 2B, lower panels) [22]. Reason-
ing that possible effects of the altered PCPTP1 levels
would be most noticeable at time points with maximal
ERK1/2 activation, we compared relative phospho-ERK1/
2 levels in the transduced cells at 2 and 5 min after EGF
addition (Fig. 2C) or at 10, 20, 30 and 60 min following
NGF administration (data not shown). Depletion of
PCPTP1, however, did not result in significant alteration
of the response to EGF or NGF administration. Also the
use of very low EGF concentrations, to ensure that ERK1/
2 is not maximally phosphorylated and PCPTP1 knock-
down may allow further increase of ERK1/2 activity, did
not reveal a significant difference in ERK1/2 activation
between mock transduced and PCPTP1 knockdown cells
(Fig. 2D).Journal of Molecular Signaling 2006, 1:4 http://www.jmolecularsignaling.com/content/1/1/4
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ERK activity profile is not affected by PCPTP1 depletion Figure 2
ERK activity profile is not affected by PCPTP1 depletion. A) RNAi-mediated knockdown of endogenous PCPTP1 in 
PC12 cells. PC12 cells stably expressing siRNA targeted to nucleotides 2380–2398 in PCPTP1 cDNA (pSR-2380) were gener-
ated via retroviral transduction. Empty vector (pSR) was used as control and PCPTP1 knockdown was rescued by transduction 
of pSR-2380-containing cells with a retroviral expression construct for the mouse ortholog PTPBR7. Equal amounts of protein 
from the resulting stable cell pools were subjected to immunoprecipitation using α-SL antiserum and captured proteins were 
analyzed on Western blots using monoclonal antibody 6A6. B) Transient and sustained ERK1/2 signaling in wild type PC12 
cells. After overnight serum deprivation, cells were stimulated with 100 ng/ml EGF (upper panels) or 50 ng/ml NGF (lower 
panels) for the indicated time points. Cell lysates were subjected to Western blot analysis and phospho-ERK1/2 signals (pERK1, 
pERK2) were detected using a chemiluminescence imaging system. The same blot was reprobed with total ERK1 antibody to 
correct for loading differences. C) Transient ERK activity is not affected in PCPTP1 knockdown cells. Serum-starved cells were 
stimulated with 10 ng/ml EGF for 2 or 5 min, respectively, and harvested. Relative phospho-ERK1/2 levels in the protein 
lysates, determined as above, are presented as mean values ± SEM from three independent experiments. D) PCPTP1 knock-
down in PC12 cells does not significantly alter ERK activity at reduced levels of EGF. Serum starved cells were stimulated with 
0.075 ng/ml EGF for the indicated time points and relative phospho-ERK1/2 levels were determined as before. Results are 
mean values ± SEM (n = 4).Journal of Molecular Signaling 2006, 1:4 http://www.jmolecularsignaling.com/content/1/1/4
Page 5 of 11
(page number not for citation purposes)
Effects of PTPRR overexpression on transient and 
sustained ERK activity
As an alternative way to assess the relevance of PTPRR
activity for the regulation of ERK signaling, we generated
pools of PC12 cells that stably expressed mouse PTPRR
isoforms by means of retroviral transduction. Lysates of
the resulting cell lines were first analyzed on Western blots
to determine PTPRR expression levels (Fig. 3A). Transduc-
tion with mouse PTPBR7-encoding viruses resulted in
immunoreactive bands that superimposed on those of
endogenous PCPTP1, confirming the previous annotation
of these signals. Ectopic expression of mouse PTPPBSγ
transcripts resulted in two additional immunoreactive
bands which represent PTPPBSγ-42 and PTPPBSγ-37 [20].
Cells transduced with a construct encoding PTP-SL, the
mouse ortholog of PCPTP1-Ce, failed to display apprecia-
ble levels of expression (not shown) and are therefore not
included in this study. Quantitation revealed that PTPBR7
expression exceeds three-fold the endogenous PCPTP1
level, whereas PTPPBSγ expressing cells show PTPRR lev-
els that are some seventeen-fold higher than in non-trans-
duced controls (Fig. 3B). Analysis of the subcellular
distribution revealed that endogenous PCPTP1 displayed
a weak vesicle-type of staining in PC12 cells, and only lim-
ited cell membrane localization (Fig 3C, left panel). In
line with previous data [20,23,24], its mouse ortholog
PTPBR7 was detected at the cell membrane, on vesicular
structures and at the Golgi apparatus (Fig. 3C, middle
panel). Mouse PTPPBSγ isoforms are cytosolic proteins
that are excluded from the nucleus, while endogenous
PCPTP1 adds a speckled pattern (Fig. 3C, right panel).
Effects of PTPBR7 and PTPPBSγ expression on ERK1/2
activity profiles in the transduced cells were again deter-
mined through phospho-ERK1/2 immunoblots (Fig. 4A).
Mean values for six independent experiments were plotted
(Fig. 4B,C) and identical results were obtained using inde-
pendently derived PC12 stably transduced cell pools.
Ectopic expression of PTPBR7 was found to have no effect
on EGF-induced transient and NGF-induced sustained
ERK1/2 activity. At 5 min following EGF addition the
PTPBR7 expressing cells display a small reduction in
ERK1/2 activity, but this does not reach significance. Like-
wise, at 2 min following EGF administration and at 10,
20, 30 or 60 min after NGF treatment the phospho-ERK1/
2 levels in the various cell pools expressing PTPPBSγ are
indifferent from those in mock-transduced cells. On the
contrary, PTPPBSγ expressing cells show a significant
reduction in ERK1/2 activity levels 5 min after EGF
administration (p < 0.008; Fig. 4B). Separate analyses of
the ERK1 and ERK2 activity levels provided essentially the
same results (data not shown). Thus, boosting PTPRR
activity in the cytosol 17-fold results in a significant ~25%
reduction of ERK1/2 activity during the later phase of the
transient response to EGF.
PTPRR effects on ERK activity involve KIM-mediated 
interactions
The binding of KIM-domain-containing phosphatases to
their MAPK targets can be abrogated by the cAMP-depend-
ent protein kinase PKA, through phosphorylation of a
specific serine residue within the KIM-domain [9,10,12].
Intriguingly, current models on transient versus sustained
ERK activation in PC12 cells incorporate an NGF-induced
PKA-mediated signaling pathway [22]. To investigate
whether this mechanism kept PTPRR isoforms from regu-
lating ERK phosphorylation levels in PC12 cells, we inves-
tigated the phosphorylation status of the KIM domain
serine residue in immunoprecipitated PTPRR proteins
Expression of PTPRR isoforms in PC12 cells Figure 3
Expression of PTPRR isoforms in PC12 cells. A) PC12 
cells were retrovirally transduced with expression constructs 
for mouse PTPRR isoforms, or mock-transduced. Equal 
amounts of cell lysates were subjected to 10% SDS-PAGE 
and immunoblotting. Rat PCPTP1, mouse PTPBR7 and 
mouse PTPPBSγ (indicated on the left) were detected using 
6A6 antibody. Molecular size markers are indicated on the 
right. The arrow indicates a cross-reactive ~50 kDa back-
ground band. B) Quantitative representation of PTPRR 
expression levels as determined in A. PTPRR levels were 
corrected for loading differences using monoclonal α-tubulin 
antibody E7 immunostaining (not shown) as a control. 
Results are the mean values ± SEM of four individual pools of 
cells. C) Subcellular localization of stably expressed PTPRR 
protein isoforms in the transduced PC12 cells as determined 
by fluorescence microscopy using polyclonal α-SL antibody. 
Bar indicates 10 µm.Journal of Molecular Signaling 2006, 1:4 http://www.jmolecularsignaling.com/content/1/1/4
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using an antibody directed against phosphorylated PKA
substrates. Administration of the PKA activator forskolin
was used to determine maximum levels of KIM-domain
phosphorylation [12]. Phosphorylation levels of endog-
enous PCPTP1 in PC12 cells were, unfortunately, below
detection level (data not shown). In PTPPBSγ-expressing
PC12 cells about half of this phosphatase appeared phos-
phorylated following overnight serum starvation, and
EGF or NGF administration even led to a significant
decrease in the phosphorylation of the regulatory serine
(Fig. 5A,B). In PTPBR7 expressing cells, however, the
PTPBR7 KIM-domain seems maximally phosphorylated
under all conditions tested (Fig. 5C, D), which may
explain the negative findings regarding ERK1/2 activity
modulation by this receptor-type PTPRR isoform.
To determine whether the phosphatase activity and/or
MAPK binding potential of PTPPBSγ is required for the
observed attenuation of the EGF-stimulated transient ERK
activity (Fig. 4), PC12 cell pools were generated that stably
express specific PTPPBSγ mutants. PTPPBSγ C343S and
D309A mutants represent catalytically impaired versions
that still may bind phosphotyrosine-containing substrates
[25]. In the ∆KIM mutant the KIM-domain has been
deleted, making it unable to associate with MAPKs [6].
Furthermore, because phosphorylation is known to regu-
late its association with MAPKs [9,13], we also included
the PTPPBSγ S94A/T116A double mutant in this series of
experiments. The PTPPBSγ mutant-expressing cell pools
demonstrated expression levels that were comparable
with or even exceeding that of wild-type PTPPBSγ express-
ing cells (Fig. 6A). Again, relative phospho-ERK1/2 levels
were determined by phospho-immunoblot analyses.
Only in PC12 cells expressing wild type PTPPBSγ or PKA-
insensitive PTPPBSγ S94A/T116A a significant decrease in
ERK1/2 activity at 5 min, but not at 2 min, following EGF
stimulation is apparent (Fig. 6B; p < 0.05). The catalyti-
cally impaired mutants as well as the version without the
KIM-domain have lost this ability, demonstrating the
requirement of a direct association with and subsequent
dephosphorylation of the MAPK by the PTP.
Discussion
The neuroendocrine PC12 cell line represents a paradigm
model system to study spatial and temporal aspects of
growth factor-induced MAPK signaling [2,26]. In this
study we made an inventory of the MAPK-associating,
phosphotyrosine-specific PTPs that are endogenously
expressed in this cell system and tested their physiological
relevance for the spatio-temporal control of EGF- and
NGF-induced ERK1/2 activity. The PTPRR isoform
PCPTP1 was the only detectable KIM-domain containing
classic PTP in these cells. Knockdown of PCPTP1 protein
levels or additional expression of its mouse ortholog
PTPBR7, however, left transient and sustained ERK1/2 sig-
PTPRR effect on growth factor-induced ERK signaling Figure 4
PTPRR effect on growth factor-induced ERK signal-
ing. A) PC12 cells stably expressing PTPPBSγ show reduced 
transient ERK1/2 activity. Serum-starved pools of mock-
transduced, PTPBR7 expressing or PTPPBSγ expressing cells 
were treated with 100 ng/ml EGF for 2 or 5 min before being 
lysed. Proteins were size-separated and immunoblotted. 
Representative images of phospho-ERK1/2 (upper panel) and 
total ERK1 (lower panel) immunoreactivity are depicted. B) 
Reduced transient ERK activity in PTPPBSγ expressing cells. 
Quantitative representation of relative phospho-ERK1/2 lev-
els in cells stimulated with EGF for two or five minutes. 
Results are presented as mean values ± SEM from six inde-
pendent experiments (Student's t-test, *p < 0.008). C) 
Increased PTPRR levels have no effect on NGF-induced 
ERK1/2 activity. Serum starved PC12 cell pools stably 
expressing PTPBR7 or PTPPBSγ were stimulated with 50 ng/
ml NGF for the indicated time points (in min). Cells were 
then lysed and phospho-ERK1/2 were analysed on Western 
blots as in panels A-B. Results are the mean ± SEM of three 
independent experiments.Journal of Molecular Signaling 2006, 1:4 http://www.jmolecularsignaling.com/content/1/1/4
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naling in response to EGF or NGF, respectively, unaltered.
Our finding that in this cell system PTPBR7 was constitu-
tively phosphorylated on a regulatory serine residue
within the KIM-domain, precluding its binding to ERK,
provides a likely explanation. Ectopic expression of the
cytosolic PTPPBSγ isoforms resulted in a decrease of EGF-
induced, but not NGF-induced, ERK1/2 activation. This
effect required PTPPBSγ enzymatic activity and an intact
KIM-domain, pointing to a direct association with and
dephosphorylation of the MAPK. In line with this, only
some 30–50% of the PTPPBSγ molecules was found to be
phosphorylated on their KIM serine residue, leaving the
majority available for engagement in ERK binding and
dephosphorylation.
It is unclear what causes the differential effect by the
PTPPBSγ isoforms as compared to the receptor-type
PTPBR7 protein on the amplitude of the transient ERK
activity following EGF administration. It may well be
attributable to the distinct subcellular localizations of
these PTPRR isoforms or rather could reflect the much
higher expression levels for PTPPBSγ-42/PTPPBSγ-37 as
compared to PTPBR7. Why PTPPBSγ ectopic expression
affects only the transient and not the sustained ERK activ-
ity profile, however, must have other grounds. Current
models incorporate an NGF-induced PKA-mediated sign-
aling pathway in PC12 cells [22] and, reasoning along
these lines, PTPPBSγ proteins may thus become hyper-
phosphorylated in the KIM-domain upon NGF addition.
In contrast, we found that treatment with EGF and NGF
both resulted in significantly lower PTPPBSγ phosphor-
ylation levels. This may be explained by assuming that the
initial boost of ERK1/2 activity following growth factor
addition results in a rapid KIM region-mediated associa-
tion of PTPPBSγ and ERK1/2, thereby protecting the regu-
latory serine in the KIM region from subsequent
Assessment of PTPRR KIM domain phosphorylation Figure 5
Assessment of PTPRR KIM domain phosphorylation. A) Lysates of PTPPBSγ expressing cells after overnight serum star-
vation (t = 0) and subsequent treatment with EGF, NGF or forskolin were subjected to immunoprecipitation with monoclonal 
antibody 6A6, and captured proteins were analyzed on blot using a phospho-PKA substrate antibody (upper panel) and 6A6 
(lower panel). It was ascertained that the phospho-PKA substrate antibody remained unreactive towards PTPPBSγ mutant 
S94A (data not shown). B) Quantitative representation of phospho-PTPPBSγ levels determined as in A. Results, expressed as 
the ratio of the signals obtained with the phospho-PKA substrate antibody and the PTPRR antibody, are presented as mean val-
ues ± SEM (n = 3, Student's t-test, *p < 0.02). C) Representative image of PTPBR7 proteins, immunoprecipitated with antibody 
6A6 from PTPBR7 expressing cells that received the indicated stimuli, as detected with phospho-PKA substrate antibody 
(upper panel) or 6A6 (lower panel). D) Quantitative representation of phospho-PTPBR7 levels as determined in C. Results are 
presented as mean values ± SEM (n = 3).Journal of Molecular Signaling 2006, 1:4 http://www.jmolecularsignaling.com/content/1/1/4
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phosphorylation. Irrespective, the PKA-mediated signal-
ing that results from NGF treatment of PC12 cells, and
that is required for the sustained nature of the ERK activity
as compared to the transient EGF effects [22], does not
explain the PTPPBSγ selective effect.
In line with our findings, ectopic overexpression of a
cytosolic version of PTP-SL (thus resembling PTPPBSγ iso-
forms) in PC12 cells has been reported previously to
result in reduced phospho-ERK5 and phospho-ERK1/2
levels following EGF administration [27]. Those data,
however, were not quantified nor tested for statistical sig-
nificance. In contrast with our studies, Ogata and cowork-
ers did observe a suppressive effect of PTPBR7 on
sustained ERK activity in PC12 cells [19]. Those experi-
ments, however, involved transient transfections that
likely result in much higher PTPBR7 expression levels, and
activation of the PC12 cells was done through co-transfec-
tion of constitutively active MEK1 instead of NGF admin-
istration. Furthermore, not ERK phosphorylation status
but transcriptional activity of its downstream substrate
Elk1 was used as a read-out, and together this may have
caused an exaggeration of effects.
PCPTP1, the rat homologue of mouse PTPBR7, is abun-
dantly expressed in several rat brain regions, including the
cerebellum, cerebral cortex and the hippocampus [17].
Intriguingly, PCPTP1 mRNA levels are increased 9-fold
over the initial 8 h of NGF-induced differentiation of
PC12 cells [14], in line with a role in neuronal differenti-
ation induced by sustained ERK activity. Our protein
knockdown experiment, however, are at odds with a criti-
cal role for PCPTP1 in ERK1/2-dependent processes in
PC12 cells. Other KIM-domain-containing tyrosine-spe-
cific PTPs cannot camouflage the impact of PCPTP1 sign-
aling since we excluded expression of other PTPRR
isoforms, STEP and HePTP/LC-PTP in PC12 cells. On the
other hand, redundancy with KIM- domain-containing
dual-specificity phosphatases (MKP/DUSP) may well
explain PTPRR's modest effect on ERK1/2 signaling. In
Drosophila, for example, redundancy regarding ERK inacti-
vation was encountered for DMKP3, a homolog of mam-
malian MKP-3/MKP-4, and PTP-ER, the Drosophila
homolog of PTPRR [28]. Potential candidates that could
take over the role of the PTPRR proteins in PC12 cells are
MKP-3, MKP-4, MKP-X and Dusp2, in view of their local-
ization in the cytoplasm and high specificity towards
ERK1/2 [5]. We detected MKP-3 and MKP-X transcripts in
PC12 cells by RT-PCR analyses (data not shown) but did
not observe alterations in growth factor-induced ERK1/2
activity profiles following RNA interference strategies
towards depletion of MKP-3 and MKP-X (data not
shown). It should be noted that verification of changes in
MKP protein levels was not performed due to lack of suit-
able antibodies.
What other substrate targets for PCPTP1 may exist in
PC12 cells to explain its endogenous presence? Besides
ERK1/2, PTPRR proteins were shown to bind the MAPK
family members p38α and ERK5 [6,9,13,27,29] but these
studies were mostly performed in non-neuronal cells,
using either recombinant proteins or ectopically
expressed phosphatases and MAPKs. Further studies
towards the identification of the physiological targets of
PTPRR isoforms are therefore needed. In addition, current
in vitro studies might be hampered by the fact that poten-
tial ligands for the PCPTP1/PTPBR7 extracellular part,
which may critically control the activity of the phos-
phatase, have not been identified yet. Also in view of the
restricted expression pattern of the Ptprr gene [17,24,30]
and its conserved potency to generate multiple protein
isoforms through the use of different promoters, alterna-
tive splicing and multiple start codons [18,20,30] it may
Wild type and non-phosphorylatable PTPPBSγ affect ERK  activity Figure 6
Wild type and non-phosphorylatable PTPPBSγ affect 
ERK activity. A) Expression analysis of wild type and 
mutant PTPPBSγ proteins. Equal amounts of protein from 
PC12 cells stably expressing wild type (WT) or mutant 
(∆KIM, D309A, S94A/T114A, and C343S) PTPPBSγ were 
subjected to SDS-PAGE and immunoblot analysis using anti-
body 6A6. B) EGF-induced ERK1/2 activity in PC12 cells sta-
bly expressing PTPPBSγ protein variants. Serum starved cells 
that stably express PTPPBSγ mutants were stimulated with 
10 ng/ml EGF for 2 or 5 min, and lysed. Relative phospho-
ERK1/2 levels were determined via immunoblot analysis as 
described in the legends to Fig. 2. Results are presented as 
mean values ± SEM (n = 4, Student's t-test; *p < 0.05).Journal of Molecular Signaling 2006, 1:4 http://www.jmolecularsignaling.com/content/1/1/4
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well be that the tyrosine phosphatase PTPRR family mem-
bers will prove physiological regulators of MAPK signal-
ing in other cell systems and following different stimuli
than the ones tested here. Given the lack of endogenous
PTPRR expression in many neuronal cell lines, studies in
PTPRR deficient mice are eagerly awaited to address their
functional significance in MAPK signaling in vivo.
Conclusion
The PTPRR isoform PCPTP1 is the sole tyrosine-specific
PTP in PC12 cells that is able to bind ERK MAPKs through
its KIM-domain and it is readily up-regulated upon
growth factor-induced differentiation of these cells. Still,
the physiological regulation of ERK1/2 signaling in PC12
cells could not be ascribed to this PTP. We conclude that
other, dual-specificity MAPK phosphatases may act as
major regulators of EGF- and NGF-induced signaling
pathways in these cells.
Methods
RT-PCR
Total RNA from exponentially growing PC12 cells, rat cer-
ebellum, mouse cerebrum or spleen was purified using
RNazol B (Campro Scientific, Veenendaal, The Nether-
lands). RT-PCR analyses were performed essentially as
described [31]. Briefly, cDNA was synthesized from total
RNA by random hexamer priming using SuperScript™ II
RNase H- Reverse Transcriptase (Invitrogen Life Technolo-
gies, Breda, The Netherlands) and used for PCR. Ampli-
fied products were analyzed on agarose gels. Primers used
are: PCPTP1-forward 5'-CCTCAATGCACACACTAT-
GAGG-3'; PCPTP1-Ce-forward 5'-CTTCAGCTCGCAGGC
TTTC-3'; PTPPBSγ  (rat)-forward 5'-GTGCAGGACGT-
GGAGGAAG-3'; PTPRR-reverse 5'-TCCTTCTTTGCTCCA-
GAT-3'; STEP-forward 5'-GAGGACTACCGGCTGCGAC-
3'; STEP-reverse 5'-GGCTCATGGCGTGGTGCAC-3';
HePTP-forward 5'-CATCTGCTCAGT GAACACACC-3';
HePTP-reverse 5'-GTCTGCTACAGTGTTGGGC-3'; β-
actin-forward 5'-GCTAGAGCTGCCTGACGG-3' and β-
actin-reverse 5'-GAGGCCAGGATGGAGCC-3'.
Plasmids
Subcloning of a XhoI-NotI fragment from pIRES2-eGFP
(Clontech) into XhoI-NotI digested retroviral plasmid
pLXSN (Clontech) generated pLXSN-IRES2-eGFP. The
BamHIsite in pLXSN-IRES2-eGFP was subsequently used
to insert the BglII insert from pSG5-PTPPBSγ-FL [20], ren-
dering pLXSN-PTPPBSγ-IRES2-eGFP. By inserting the N-
terminus-encoding  EcoRI fragment from PTPBR7-eGFP
[23] into EcoRI-digested pLXSN-PTPPBSγ-IRES2-eGFP we
generated pLXSN-PTPBR7-IRES2-eGFP. Mutant pLXSN-
PTPPBSγ constructs were generated as follows. First
mutant PTP-SL open reading frames were excised from
pRK5-PTP-SL expression vectors ([6] kindly provided by
dr. R. Pulido, Valencia, Spain) using NotI and XhoI, and
ligated in between the corresponding sites in pLXSN.
Using BstBI we subsequently excised the mutation-con-
taining sequence parts from the obtained plasmids and
inserted them into BstBI-digested pLXSN-PTPPBSγ-IRES2-
eGFP. For siRNA constructs, appropriate oligonucleotides
were annealed and ligated in the pSUPER-Retro vector
pSR [21]. Plasmids pSR-1211 and pSR-2380 encode siR-
NAs that target the nucleotides 1211–1229 and 2380–
2398 in the PCPTP1 mRNA [Genbank:D38292], respec-
tively. All constructs were verified by sequence analysis.
Cell culture and retroviral transduction
PC12 cells (ATCC #CRL-1721) were grown on collagen-
coated dishes in DMEM supplemented with 10% FCS and
5% horse serum (HS) at 37°C. Ecotropic Phoenix packag-
ing cells [32] were cultured in DMEM, 10% FCS. For ret-
rovirus production, Phoenix cells were transiently
transfected by calciumphosphate precipitation. Twenty-
four hours after transfection, medium was replaced by
DMEM containing 10% FCS and 5% HS. After 10 h retro-
virus-containing medium was collected, filtered through a
0.45-µm pore-size filter and supplemented with poly-
brene (Sigma-Aldrich Chemie B.V., Zwijndrecht, The
Netherlands) to a final concentration of 5 µg/ml. PC12
cells were infected by replacing culture medium with
undiluted polybrene- and retrovirus-containing medium
for 8–16 h. After four subsequent rounds of infection,
transduced cells were selected for 2–3 weeks in medium
containing 500 µg/ml G418 (Gibco Europe, Breda, The
Netherlands) or 2.5 µg/ml puromycin (Sigma-Aldrich
Chemie B.V.), respectively.
Immunoblot analysis
Cells were seeded in six-well plates at a density of 1*106
cells/well. The next day medium was replaced by DMEM
without serum. After o/n serum deprivation, cells were
treated with 0.075–100 ng/ml EGF (a kind gift of Dr. J.
van Zoelen, Nijmegen, The Netherlands) or 50 ng/ml
NGF (N6009, Sigma-Aldrich Chemie B.V.) for different
time periods. Cells were washed twice with ice-cold phos-
phate-buffered saline (PBS) before being scraped with a
rubber policeman in 75µl lysis buffer: 50 mM Tris-HCl,
pH 7.5; 150 mM NaCl; 1% triton X-100; 100 mM NaF; 2
mM Na3VO4; 20 mM Na4P2O7; 1 mM PMSF; protease
inhibitor cocktail (Roche Diagnostics GmbH, Mannheim,
Germany). Lysis was continued on ice for 30 min and
insoluble components were subsequently pelleted by cen-
trifugation for 25 min at 14.000 rpm and 4°C. Superna-
tants were stored at -20°C until further use. Protein
concentrations were determined spectrophotometrically
[33].
Protein samples (8 µg) were subjected to SDS-PAGE on
10% PA gels and blotted onto polyvinylidene fluoride
(PVDF) membranes. Blots were blocked for 30 min usingJournal of Molecular Signaling 2006, 1:4 http://www.jmolecularsignaling.com/content/1/1/4
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3% non-fat dry milk in TBS-T (10 mM Tris-HCl, pH 8.0;
150 mM NaCl; 0.05% Tween-20) and incubated over-
night at 4°C with a 1:2000 dilution of a phospho-ERK1/2
monoclonal antibody (#9106, Cell Signaling Technology,
Beverly, USA). Following three washes with TBS-T, blots
were incubated for 1 h with a 1:10,000 dilution of perox-
idase-conjugated goat anti-mouse IgG (Pierce Biotechnol-
ogy Inc., Rockford, IL, USA) in 3% non-fat dry milk in
TBS-T. Immunoreactive bands were detected with Lumi-
LightPLUS Western Blotting Substrate (Roche Diagnostics
GmbH) using a BioChemi imaging system and obtained
signals were quantified with the Labworks 4.0 program
(UVP BioImaging Systems, Cambridge, UK). Blots were
then stripped for 40 min at 60°C (in 62.5 mM Tris-HCl,
pH 6.6; 100 mM β-mercapto-ethanol; 2% SDS), washed
with TBS-T and reprobed for 1 h with rabbit polyclonal
ERK1 (C-16) antibody (sc-93, Santa Cruz Biotechnology,
Inc., Santa Cruz, USA) at a dilution of 1:8000 in TBS-T
containing 3% non-fat dry milk. Peroxidase-conjugated
goat anti-rabbit IgG (Pierce Biotechnology Inc.) was used
for detection and quantitation as described above. Ratios
of the phospho-ERK1/2/total ERK1 signals were deter-
mined for every sample and, to be able to compare signal
ratios originating from different blots, a reference stand-
ard sample (corresponding to a PC12 cell lysate following
5 min treatment with EGF) was included on each blot.
PTPRR expression levels were determined by subjecting
50  µg of total protein to SDS-PAGE and immunoblot
analysis as described above, using monoclonal antibody
6A6 [20]. Phospho-PTPPBSγ and phospho-PTPBR7 levels
were determined by western blotting of 6A6 immunopre-
cipitates, performed as described previously [20], from
PTPPBSγ or PTPBR7 expressing cells which had been incu-
bated with 10 ng/ml EGF, 50 ng/ml NGF or 10 µM forsko-
lin after overnight serum starvation. Blots were incubated
simultaneously with a rabbit monoclonal phospho-PKA
substrate (RRXS*/T*)(100G7) antibody (#9624, Cell Sig-
naling Technology) and with 6A6, both in a 1:1000 dilu-
tion. Goat anti-mouse and goat anti-rabbit secondary
antibodies conjugated to Alexa Fluor 680 (Molecular
Probes) or IRDye800 (Rockland Immunochemicals) fluo-
rescent dyes were used for detection and quantification on
an Odyssey infrared imaging system (LI-COR).
Immunofluorescence microscopy
Cells, cultured on collagen-coated coverslips, were fixed at
room temperature for 30 min in PHEM buffer (60 mM
PIPES; 25 mM HEPES, pH 6.9; 10 mM EGTA; 2 mM
MgCl2) containing 4% paraformaldehyde, and subse-
quently washed with PBS and permeabilized for 5 min
using 0.2% Triton X-100 in PBS. Aspecific sites were
blocked by incubating for 30 min with 4% BSA in PBS
before cells were incubated for 1 h with a 1:500 dilution
of rabbit polyclonal α-SL antiserum [24] in PBS contain-
ing 0.4% BSA. Following three washes with PBS, cells were
incubated for 1 h in a 1:300 dilution of Alexa568-conju-
gated goat-anti-rabbit IgG (Molecular Probes) in PBS,
0.4% BSA. Following PBS washes and methanol dehydra-
tion, coverslips were mounted on glass slides using
Mowiol (Sigma-Aldrich), and images were collected using
confocal laser scanning microscopy (MRC1024, Bio-rad).
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